Menu

1 / 24

Procter & Gamble: When Defense Becomes Risky

All Articles on Seeking Alpha·1 day ago
#OKE63OrY
#seekingalpha#growth#chart#sales#organic
Reading 0:00
15s threshold

Bay Area Ideas 6.06K Followers

Summary

I reiterate my Sell rating on Procter & Gamble. Sales are recovering, but shaky margins and an elevated valuation undermine risk/reward.

Fiscal Q1 organic sales grew 4%, driven primarily by volume and mix, while core gross margin ex-FX contracted 150 basis points.

FY2027 guidance implies 2% organic sales growth and 1.5% core EPS growth at the midpoints, making profitability the key recovery metric to scrutinize moving forward.

Procter & Gamble's 2.59% forward dividend yield and meaningful buybacks reward long-term holders, but a 24.10 forward P/E remains detached from slow-growth fundamentals.

BalkansCat/iStock Editorial via Getty Images

Introduction

Back in late May, I provided an update for The Procter & Gamble Company (PG) and decided to reiterate my sell rating on the stock.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.